Jan Hillert

Karolinska Institutet - Department of Clinical Neuroscience

Stockholm, 171 77

Sweden

SCHOLARLY PAPERS

2

DOWNLOADS

119

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Increased Rate of Hospitalisation for COVID-19 Amongst Rituximab Treated Multiple Sclerosis Patients: A Study of the Swedish MS Registry

Number of pages: 21 Posted: 10 Mar 2021
Karolinska Institutet - Department of Clinical Neuroscience, Swedish MS Registry - Department of Clinical Neuroscience, Karolinska Institutet, Karolinska Institutet and Karolinska Institutet - Department of Clinical Neuroscience
Downloads 108 (312,000)

Abstract:

Loading...

multiple sclerosis, covid-19, rituximabb

2.

The Effect of Different National Treatment Strategies on Disability Outcome in Relapsing-Remitting Multiple Sclerosis: A Propensity Score Adjusted Comparison between Denmark and Sweden

Number of pages: 31 Posted: 18 Mar 2021
Karolinska Institutet - Department of Clinical Neuroscience, University of Copenhagen - Department of Pediatrics, Karolinska Institutet - Neuroimmunology Unit, Karolinska Institutet, Aarhus University Hospital - Department of Neurology, University of Southern Denmark - MS Clinic Southern Denmark, University of Copenhagen - Rigshospitalet, University of Copenhagen - Rigshospitalet, Karolinska Institutet - Department of Clinical Neuroscience and Sahlgrenska University Hospital - Department of Neurology
Downloads 11 (708,228)

Abstract:

Loading...

multiple sclerosis, treatment strategies, registries, disease modifying treatments